<DOC>
	<DOCNO>NCT00152516</DOCNO>
	<brief_summary>To allow pediatric patient partial onset seizure opportunity receive ( follow-up study N01009 ( NCT00105040 ) /N01103 ( NCT00175890 ) direct enrollment ) open-label levetiracetam treatment , continue study cognition behavior child , continue collection safety/efficacy data .</brief_summary>
	<brief_title>Long-Term , Follow-Up Study Of Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Pediatric patient partial onset seizure , 1 2 antiepileptic drug ( AEDS ) , participation previous levetiracetam pediatric study ( N01009 N01103 ) direct enrollment , levetiracetam treatment possible benefit Patients ketogenic diet Seizures close together accurately count Pseudoseizures Status epilepticus 1 month prior Visit 1 Current diagnosis LennoxGastaut Syndrome epilepsy secondary progress cerebral disease exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Partial Onset Seizures</keyword>
	<keyword>levetiracetam</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>Keppra</keyword>
</DOC>